Preparation method and application of transgenic mouse with severe immunodeficiency

A technology for transgenic mice and immunodeficiency, applied in the biological field, can solve the problem that the endogenous NGF gene in mice cannot be deleted correctly

Inactive Publication Date: 2020-08-04
澎立生物医药技术(上海)股份有限公司
View PDF7 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are many difficulties or risks in obtaining mice with NGF gene knock-in by conventional gene knock-in technology. Screening, a negative screening to obtain positive clones
After the homologou

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of transgenic mouse with severe immunodeficiency
  • Preparation method and application of transgenic mouse with severe immunodeficiency
  • Preparation method and application of transgenic mouse with severe immunodeficiency

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0062] The technical solution of the present invention will be further described below in combination with specific embodiments.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method and application of a transgenic mouse with severe immunodeficiency. The method comprises the step of knocking out a gene for encoding a gamma chain of an interleukin-2 receptor in a mouse chromosome through a CRISPR/CAS9 technology, exons 1 and 2 of a gene of a gamma chain of an interleukin-2 receptor are selected as knockout sites, and Cas9 messenger RNA and guide RNA are jointly injected into fertilized eggs of a mouse through microinjection. The mouse with severe immunodeficiency cannot generate T, B and NK immune cells, so that the greatest convenient condition is created for transplantation of human hematopoietic stem cells.

Description

technical field [0001] The invention relates to a preparation method and application of a severe immunodeficiency transgenic mouse, belonging to the field of biotechnology. Background technique [0002] The human immune response needs to be carried out in vivo, and due to ethical restrictions, it is not possible to directly use humans as experimental subjects. Rodents are small animal models widely used in experimental research. At present, most studies on the development, differentiation and function of the immune system come from these models. However, due to the existence of species specificity, the conclusions obtained from rodent models cannot be directly derived from humans. immune system. Human hematopoietic immune function research, infectious diseases, autoimmune diseases and tumor research are difficult to achieve dynamic observation in vivo. Some researchers use primates as substitutes, trying to make up for the huge species difference between humans and rodents...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/90C12N15/12A01K67/027A61K49/00
CPCA01K67/0271A01K67/0276A01K2207/12A01K2217/075A01K2227/105A01K2267/03A61K49/0008C07K14/7155C12N15/907
Inventor 黄哲夫杨楠陈洁罗艳段继峰
Owner 澎立生物医药技术(上海)股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products